Work

Risk Factors for Dementia and Cognitive Decline

Year: 2003
Type: report
Abstract: Methodological issues• In assessing the findings from epidemiological work, a number of methodological issues concerned with definition and measurement, and the design of the study, have to be taken into account.• The presence of the disorder or type of disorder must be capable of being reliably assessed, as must the strength of exposure to risk factors.• The design of the study can strongly influence the findings.Early empirical research was based on case-control studies of prevalence, but large longitudinal studies of incidence are needed to distinguish between association and causality, and to examine interactions between risk factors.• There may be various explanations for some of the findings of epidemiological studies. PART II -RISK FACTORS FOR DEMENTIA AND COGNITIVE DECLINE Age, gender, ethnic and national factors• Cognitive function declines with age, although there are wide individual differences, and also differences between domains in the rate of decline.• Both the prevalence and incidence of dementia increase exponentially with age.Key issues are the size (or relative importance) of 'age' as a risk factor, and explanations for the effect of ageing.• Age has generally been seen as the main risk factor for dementia, but there is debate about whether the 'cause' should be seen in terms of ageing per se (in which case everyone would develop dementia if they lived for long enough), or the ageing-related increasing incidence of disease.• There are gender differences in the prevalence of dementia, but whether these reflect differences in incidence is still unclear.• By contrast with other chronic disorders, cross-cultural studies have thrown little light on causal factors.The difficulty of separating biological and environmental factors has been widely acknowledged. Genetic factors• Early onset Alzheimer's disease is strongly related to family history, and three genetic mutations associated with this disorder have been identified.Although cases of earlyonset Alzheimer's disease account for a small proportion of cases of dementia overall, a high proportion of such cases are thought to be associated with these genes.• One genetic mutation has been linked with some forms of late onset dementia including Alzheimer's disease.This is the APOE 4 allele.However, the presence of APOE 4 is neither necessary nor sufficient to cause Alzheimer's disease; only about half of affected individuals carry the allele.• Other genetic factors are being investigated.• At the moment, research findings have not suggested any means of prevention.• An increased knowledge of genetic factors has been seen as useful in gaining a better understanding of the mechanisms underlying the development of dementia. Pre-existing conditions• A number of conditions can predispose to dementia of the Alzheimer type.These include Risk Factors for Dementia and Cognitive Decline 9Down's syndrome and Parkinson's disease.Some studies have found an association with thyroid disease but others have not.• Pathological and genetic associations between Down's syndrome and Alzheimer's disease have been found.The incidence of dementia of this type occurs 30 -40 years earlier in the population of people with Down's syndrome than in the general population.• The prevalence of dementia in people with Parkinson's disease is thought to be between 28 -40%, i.e. considerably higher than in the general population. Physical injury, illness and medication• There is some evidence that brain injury increases the risk of cognitive decline.• There is evidence to support a link between head trauma and loss of consciousness and an increased risk of Alzheimer's disease, although not all studies show this.• There is some evidence to suggest that herpes simplex type 1 virus (HSV1) may be a risk factor in individuals who carry the APOE 4 allele.If this is the case, it is possible that some cases of Alzheimer's disease could be prevented by vaccination.• The link with aluminium suggested by some early studies has not been proved.• A few studies have examined exposure to other toxins and pollutants, but the findings are inconclusive.• There is some evidence of a link between non-steroidal anti-inflammatory drugs (NSAIDs) and a reduced risk of Alzheimer's disease, although this protective effect remains to be confirmed by clinical trials.NSAIDs have a number of side effects that preclude their widespread use. Risk factors for vascular disease• The risk factors for vascular dementia are relatively well understood.These include cerebro-vascular disease, and risk factors for vascular disease, such as hypertension, diabetes and obesity.• An association has recently been found between vascular factors found in mid-life (e.g.hypertension) and Alzheimer's disease.At the same time, low blood pressure has sometimes been found among people with the disorder.• Findings from recent large studies have indicated that high blood pressure measured in mid-life is also a significant predictor of poorer cognitive function in later life.• The long-term cognitive decline experienced by a minority of heart bypass patients is being investigated. Smoking, alcohol and drug use• Smoking is a known risk factor for vascular dementia.• Findings from studies examining smoking and the risk of Alzheimer's disease have varied.It has been concluded that any effect, in either direction, is likely to be small.• High alcohol intake is linked with cognitive impairment, although the effects may be reversible.It is also the commonest cause of Wernicke-Korsakoff syndrome, the main feature of which is memory impairment.• Alcohol use is thought to contribute to a significant proportion (10%) of cases of dementia.A high intake of alcohol is associated with vascular disease and, hence, with vascular dementia.Also, although alcohol per se might not cause dementia, it has been seen as a contributory factor in conjunction with other factors, particularly nutritional deficiencies. EXECUTIVE SUMMARY• Although there is interest in the long term effect of recreational drug use on the brain, drug use has not been examined as a risk factor. Diet, nutrition and hormones• Weight loss is commonly associated with Alzheimer's disease, and a number of possible explanations have been suggested.• Nutritional deficiency has been found to affect cognition, and associations with dementia are being investigated.• A deficiency of B vitamins (B12, B6 and folate) has been found to be correlated with increased serum homocysteine (tHcy) concentrations.Low levels of B vitamins have been associated with lower levels of cognitive function.Similarly, a high concentration of homocysteine (or folate deficiency) has been associated with an increased risk of dementia, particularly Alzheimer's disease.• Clinical trials of vitamin B supplements for people with Alzheimer's disease are planned, and these may be extended to people with mild memory impairment.• High cholesterol levels are associated with an increased risk of vascular disease and hence vascular dementia.There is evidence of an association between high levels of dietary saturated fat, or high cholesterol level, in mid-life and an increased risk of cognitive decline and dementia.• There is some evidence to suggest that regular consumption of foods rich in N-3 polyunsaturated fatty acids may decrease the risk of Alzheimer's disease.• Statins (one type of lipid-lowering agent) have been found to lower the risk of vascular disease and mortality from all causes.There is also some evidence that they reduce the risk of developing Alzheimer's disease.Clinical trials are under way.• Clinical intervention studies are examining whether anti-oxidant vitamins might reduce the risk of dementia.Findings have been contradictory, but tend to suggest that vitamins from food sources are more effective than supplements.• Some observational studies have suggested that oestrogen use in post-menopausal women can have a beneficial effect on cognitive function.However, the evidence for a protective role against the development of dementia is weak.The effects of oestrogen and HRT use are being investigated, although long term trials have been halted.• Reviewers of the literature have emphasised that nutritional factors should be considered in conjunction with others, and that there may be a number of possible explanations. To what extent, if any, might interventions currently targeted at vascular disease have helpful impacts on dementia or cognitive decline?• The fact that some dementia and cognitive decline is linked with vascular factors, particularly hypertension, suggests that there is some scope for intervention.Treatment of hypertension has been established, and has been found to be effective in reducing the risk of vascular events.Thus, vascular dementia may be preventable, to an extent, by medication and/or lifestyle change.• However, little is known about whether interventions targeted at vascular disease have any impact on the incidence of dementia or cognitive decline.• The identification of those whose age, sex, smoking and blood pressure indicate a high risk of vascular disease is felt to be worthwhile in relation to vascular risk, and may be worthwhile in relation to dementia.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W355162490
Cites: 93
Cited by: 9
Related to: 9